KeyCorp Issues Positive Forecast for Hinge Health (NYSE:HNGE) Stock Price\n\nJuly 14, 2025\n\nHinge Health ( - ) had its target price increased by KeyCorp from $45.00 to $60.00 in a report published on Monday morning, reports. KeyCorp currently has an overweight rating on the stock. Get **Hinge Health** alerts: Sign Up Other analysts have also issued research reports about the company. Evercore ISI started coverage on Hinge Health in a report on Monday, June 16th. They set an \"outperform\" rating and a $50.00 target price for the company. Royal Bank Of Canada initiated coverage on Hinge Health in a research note on Monday, June 16th. They set an \"outperform\" rating and a $45.00 price objective for the company. Needham &amp; Company LLC started coverage on Hinge Health in a research note on Monday, June 16th. They issued a \"buy\" rating and a $47.00 target price on the stock. Barclays increased their price target on shares of Hinge Health from $43.00 to $51.00 and gave the company an \"overweight\" rating in a research report on Monday. Finally, Piper Sandler started coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued an \"overweight\" rating and a $41.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, Hinge Health currently has an average rating of \"Moderate Buy\" and a consensus price target of $49.36.\n\nHinge Health Stock Performance Shares of traded up $0.55 during trading hours on Monday, hitting $48.19. The company's stock had a trading volume of 830,694 shares, compared to its average volume of 1,045,669. Hinge Health has a 52 week low of $33.42 and a 52 week high of $52.16.\n\nAbout Hinge Health () Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

Hinge Health (NYSE:HNGE) Stock Price Expected to Rise, KeyCorp Analyst Says

KeyCorp raised its target price for Hinge Health (NYSE:HNGE) from $45.00 to $60.00, with an overweight rating. Multiple analysts, including Evercore ISI, Royal Bank Of Canada, and Piper Sandler, initiated coverage or updated ratings for the company. Hinge Health's stock rose $0.55 to $48.19 on Monday, with a trading volume of 830,694 shares.